Anti-SH2B3 monoclonal antibody

Pre-made anti-SH2B3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SH2B3/SH2B3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T44585-Ab-1/ GM-Tg-hg-T44585-Ab-2Anti-Human SH2B3 monoclonal antibodyHuman
GM-Tg-rg-T44585-Ab-1/ GM-Tg-rg-T44585-Ab-2Anti-Rat SH2B3 monoclonal antibodyRat
GM-Tg-mg-T44585-Ab-1/ GM-Tg-mg-T44585-Ab-2Anti-Mouse SH2B3 monoclonal antibodyMouse
GM-Tg-cynog-T44585-Ab-1/ GM-Tg-cynog-T44585-Ab-2Anti-Cynomolgus/ Rhesus macaque SH2B3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T44585-Ab-1/ GM-Tg-felg-T44585-Ab-2Anti-Feline SH2B3 monoclonal antibodyFeline
GM-Tg-cang-T44585-Ab-1/ GM-Tg-cang-T44585-Ab-2Anti-Canine SH2B3 monoclonal antibodyCanine
GM-Tg-bovg-T44585-Ab-1/ GM-Tg-bovg-T44585-Ab-2Anti-Bovine SH2B3 monoclonal antibodyBovine
GM-Tg-equg-T44585-Ab-1/ GM-Tg-equg-T44585-Ab-2Anti-Equine SH2B3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T44585-Ab-1/ GM-Tg-hg-T44585-Ab-2; GM-Tg-rg-T44585-Ab-1/ GM-Tg-rg-T44585-Ab-2;
GM-Tg-mg-T44585-Ab-1/ GM-Tg-mg-T44585-Ab-2; GM-Tg-cynog-T44585-Ab-1/ GM-Tg-cynog-T44585-Ab-2;
GM-Tg-felg-T44585-Ab-1/ GM-Tg-felg-T44585-Ab-2; GM-Tg-cang-T44585-Ab-1/ GM-Tg-cang-T44585-Ab-2;
GM-Tg-bovg-T44585-Ab-1/ GM-Tg-bovg-T44585-Ab-2; GM-Tg-equg-T44585-Ab-1/ GM-Tg-equg-T44585-Ab-2
Products NameAnti-SH2B3 monoclonal antibody
Formatmab
Target NameSH2B3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SH2B3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T44585-Ag-1Recombinant multi-species SH2B3/ IDDM20/ LNK protein
    ORF Viral VectorvGMLV000209human SH2B3 Lentivirus particle
    ORF Viral VectorpGMLV000209human SH2B3 Lentivirus plasmid


    Target information

    Target IDGM-T44585
    Target NameSH2B3
    Gene ID10019,16923,58838,710839,100683018,101081760,614726,100057885
    Gene Symbol and SynonymsIDDM20,LNK,SH2B3
    Uniprot AccessionQ9UQQ2,P50745
    Uniprot Entry NameSH2B3_HUMAN,SH2B3_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000111252
    Target ClassificationN/A

    The target: SH2B3, gene name: SH2B3, also named as IDDM20, LNK. This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.